MR imaging of hepatocellular carcinoma using hepatocyte-specific contrast agent Gd-EOB-DTPA

DOI 33 References
  • TANAKA Osamu
    Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • NISHIMURA Tsunehiko
    Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • YAMAGAMI Takuji
    Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
  • ICHIJO Yusuke
    Department of Radiology, Osaka Railway Hospital
  • OUCHI Hiroyuki
    Department of Radiology, Osaka Railway Hospital
  • OHNO Koji
    Department of Radiology, Osaka Railway Hospital
  • MITSUMOTO Yasuhide
    Department of Gastroenterology, Osaka Railway Hospital
  • MORI Takahiro
    Department of Gastroenterology, Osaka Railway Hospital
  • YOSHIKAWA Toshikazu
    Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Bibliographic Information

Other Title
  • 肝細胞特異性MRI造影剤（Gd-EOB-DTPA）を用いた肝細胞癌画像診断

Search this article

Description

画像診断装置の性能向上および造影剤の進歩により，肝細胞癌の画像診断は近年飛躍的に進歩した．2008年1月に肝細胞特異性造影剤であるGod-EOB-DTPA（gadolinium ethoxybenzyl diethlenetriamine pentaacetic acid，ガドキセト酸ナトリウム；EOB・プリモビスト®）が本邦で発売され，約2年が経過した．肝細胞機能評価のみならず，これまでの細胞外液性MRI造影剤の性能を併せ持っているために1回の検査で血流評価と肝細胞機能評価が同時に可能となり，肝細胞癌の診断，特に境界・前癌病変と癌との鑑別においてその有用性が期待される．<br>

Journal

References(33)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top